Pfizer Inc. (PFE)

38.39
0.12 0.31
NYSE
Prev Close 38.27
Open 38.30
Day Low/High 38.16 / 38.62
52 Wk Low/High 27.88 / 40.97
Volume 13.96M
Exchange NYSE
Shares Outstanding 5554.83B
Market Cap 213.58B
P/E Ratio 13.73
Div & Yield N.A. (N.A)
Back to Back Wins for Bristol-Myers, and Here's How I'd Trade It

Back to Back Wins for Bristol-Myers, and Here's How I'd Trade It

BMY sees reason for optimism over the final half of the year.

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.

McDonald's Investors Have a Choice to Make Now

McDonald's Investors Have a Choice to Make Now

How I'd play the Golden Arches after its quarter pounding.

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Caution Signs, Laboring Labor Market, Gold Watch and Ugly Intel: Market Recon

Caution Signs, Laboring Labor Market, Gold Watch and Ugly Intel: Market Recon

Plus, why shares of vaccine maker Moderna are taking a hit.

If You Can Trade These Markets, You Can Survive in Almost Any Environment

If You Can Trade These Markets, You Can Survive in Almost Any Environment

If you are out of step with the marketplace, do not blame the marketplace. Understand that you have failed to adapt.

Price Is Now Just a Number, but There's a Catch

Price Is Now Just a Number, but There's a Catch

The hitch is that fundamentals do matter, too. Confused? Let's examine what's happening in the market and why it's making me cautious.

Novavax and Its $1.6 Billion Award Just Got My Attention

Novavax and Its $1.6 Billion Award Just Got My Attention

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.

Q2 Earnings Expectations, Phase 3 Vaccine Clinical Trials, Unemployment Numbers

Q2 Earnings Expectations, Phase 3 Vaccine Clinical Trials, Unemployment Numbers

What if the market is simply pricing in a quarter that had already been priced out?

Pfizer's Pullback Sweetens the Pill

Pfizer's Pullback Sweetens the Pill

The drugmaker is a buying opportunity right now.

Dazed and Confused, Jobs Report, More 'Helicopters' on the Way, Trading Boeing

Dazed and Confused, Jobs Report, More 'Helicopters' on the Way, Trading Boeing

Equity markets had a tougher day on Wednesday than immediately meets the eye. And did you catch what Trump said?

I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

Jim Cramer: Are You a Star Player? Let's Put It to the Test

Jim Cramer: Are You a Star Player? Let's Put It to the Test

Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?

Jim Cramer: Is the Day Where the Virus Ruled Our Lives Waning?

Jim Cramer: Is the Day Where the Virus Ruled Our Lives Waning?

That's the really good news about why we could bounce back so quickly from Thursday's debacle.

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

Warp Speed for 5 Vaccine Candidates, Watching KLA Corp, Trading Thoughts

The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.

Jim Cramer: What's Normalcy in This Country?

Jim Cramer: What's Normalcy in This Country?

We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.

Watching Price Action, Pfizer Selloff, Trading Thoughts

Watching Price Action, Pfizer Selloff, Trading Thoughts

Taking a chunk of Pfizer during this selloff, while Amazon has raised $10 billion in mixed-maturity debt and all eyes are on the government's response to civil unrest in the U.S.

China Headline Risk, Valuation Station and a Workday Play

China Headline Risk, Valuation Station and a Workday Play

WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

Merck Is All In With a Threefold Approach to Covid-19

Merck Is All In With a Threefold Approach to Covid-19

I've been long Merck for a long time, since way before this pandemic became part of our lives.

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.

The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'

The Fed Has Our Backs, Trading Thoughts, 'Facebook Shops'

As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.

Jim Cramer: It's Still Better to Be Safe Than Sorry

Jim Cramer: It's Still Better to Be Safe Than Sorry

Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.

Moderna Is a Breath of Fresh Air

Moderna Is a Breath of Fresh Air

I'm long this name, as I am several of the others involved. Will I add on a day like this?

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.